Epoli: The company has currently stopped the production of vitamin B12.

Yidoli stated at the performance briefing on September 19th that, due to market reasons, the company has currently stopped the production of vitamin B12. In terms of animal plant extracts, the company has continued to conduct comprehensive pharmacological research and toxicological experiments on the whole plant of Boluo Hui in the first half of the year. They have completed trials on Boluo Hui scatter-fed chickens, "meiwuyi" meat chickens, Bobo total alkaloid scatter-fed meat chickens, and Sangbaipi water extracts fed chickens, and obtained new product certificates for red clover extract and stone sage extract feed and feed additives. In terms of human plant extracts, the company has developed products such as cherry frozen fruit fermented products, bamboo leaf extracts, huangbo tree bark extract, purple cone flower microcrystalline cellulose composite powder, etc. In addition, they have optimized the extraction processes for sorghum, lingzhi, rose eggplant, cocoa, and other plants, continued to expand overseas markets, and increased sales in the European and Southeast Asian markets. The preparations for the German subsidiary have been completed, and efforts are being made to achieve sales breakthroughs this year.